Fact CheckerSign in

NCT06265922Completed

Cerebellar RTMS in Patients with Multiple Sclerosis

Effect of Cerebellar Repetitive Transcranial Magnetic Stimulation on Coordination in Patients with Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 19 Feb 2025

Brief summary (registry, in English)

To determine the efficacy of high frequency cerebellar repetitive transcranial magnetic stimulation on coordination in patients with multiple sclerosis.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
11 Feb 2024
Start date
18 Feb 2024
Primary completion date
17 Jul 2024
Lead sponsor
Cairo University
NCT number
NCT06265922

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 18 Feb 2024 to the primary completion date, 17 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous surgeries in the brain.
  • Any magnetic or metallic devices implanted (like cochlear implants) .

Other illness

  • Secondary musculoskeletal complication such as contractures or deformities. Cardiovascular, pulmonary, hepatic, renal, hemopoietic and thyroid diseases.
  • Psychotic deficits or history of epileptic seizures.

Other

  • Any other neurological deficits or orthopedics abnormalities.
  • Ataxic manifestations for other cause rather than Multiple Sclerosis.
  • Other neurological manifestations (e.g. spasticity, visual loss)
  • Pregnant women.
  • Addicted individuals.

Who the study is looking for

  • Clinically definite MS (relapsing, remitting and secondary progressive) patients
  • Patients who are medically stable and Free from relapses three months before
  • Ambulant patients without an assistive device and score less than 5 on the Kurtzke Expanded Disability Status Scale (EDSS)
  • Patients receiving their disease modifying drugs but no medication changing during the previous three months.
  • Patients who had MRI evidence of lesions in the cerebellum or in the cerebellar pedunculi.
  • Right handed patients.
  • Severity of ataxia range from 4 to 10 according to scale of assessment and rating ataxia (SARA).
  • Did not apply cerebellar transcranial magnetic stimulation before.

Age in the registry: 20 years to 45 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faculty of Physical Therapy, Cairo University
Coordinator of this site? Confirm its status
GizaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.